AI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO says Sanofi's CEO said the ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

A team of scientists at the University of Toronto have successfully implemented AI tools to speed up the process of ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

Drugmakers, academics and logistics professionals are using artificial intelligence to address the industry’s most pressing ...

XtalPi Holdings, an artificial intelligence (AI) drug discovery firm based in the Greater Bay Area, is changing the ...

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...